Overcoming Barriers to Prevention, Care, and Treatment of Hepatitis C in Illicit Drug Users
Year: 2005
Type: review
Abstract: Injection drug use accounts for most of the incident infections with hepatitis C virus (HCV) in the United States and other developed countries. HCV infection is a complex and challenging medical condition in injection drug users (IDUs). Elements of care for hepatitis C in illicit drug users include prevention counseling and education; screening for transmission risk behavior; testing for HCV and human immunodeficiency virus infection; vaccination against hepatitis A and B viruses; evaluation for comorbidities; coordination of substance-abuse treatment services, psychiatric care, and social support; evaluation of liver disease; and interferon-based treatment for HCV infection. Caring for patients who use illicit drugs presents challenges to the health-care team that require patience, experience, and an understanding of the dynamics of substance use and addiction. Nonetheless, programs are successfully integrating hepatitis C care for IDUs into health-care settings, including primary care, methadone treatment and other substance-abuse treatment programs, infectious disease clinics, and clinics in correctional facilities.
Source: Clinical Infectious Diseases
DOI: 10.1086/427441
Institutions: Cornell University, Weill Cornell Medicine, National Institute on Drug Abuse, New York University, Brown University, Miriam Hospital, United States Department of Health and Human Services, Health Resources and Services Administration, National Institutes of Health, Office of AIDS Research
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,763
OpenAlex ID: W2138434459
